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Objective: To undertake a cost-utility analysis of the Individ-
ual Nutrition Therapy and Exercise Regime: A Controlled 
Trial of Injured, Vulnerable Elderly (INTERACTIVE) trial. 
Design: Cost-utility analysis of a randomized controlled 
trial. 
Subjects: A total of 175 patients following a hip fracture 
were allocated to receive either alternate weekly visits from 
a physical therapist and dietitian (intervention group), or so-
cial visits for 6 months (control group). 
Methods: Costs for utilization of hospitals, health and com-
munity services were compared with quality-adjusted life 
years gained, calculated from responses to the Assessment of 
Quality of Life instrument. 
Results: There were minimal differences in mean costs be-
tween the intervention ($AUD 45,331 standard deviation 
(SD): $AUD 23,012) and the control group ($AUD 44,764 
SD: $AUD 20,712, p = 0.868), but a slightly higher mean 
gain in quality-adjusted life years in the intervention group 
(0.155, SD: 0.132) compared with the control group (0.139, 
SD: 0.149, p = 0.470). The incremental cost-effectiveness ra-
tio was $AUD 28,350 per quality-adjusted life year gained, 
which is below the implied cost-effectiveness threshold uti-
lized by regulatory authorities in Australia. 
Conclusion: A comprehensive 6-month programme of thera-
py from dietitians and physical therapists could be provided 
at a relatively low additional cost in this group of frail older 
adults, and the incremental cost-effectiveness ratio indicates 
likely cost-effectiveness, although there was a very high level 
of uncertainty in the findings. 
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INTRODUCTION
The devastating effect of hip fractures on function and inde-
pendence has been well documented. The cost to the com-
munity for treating and providing community support was 
estimated as $AUD 227 million in 1994 (1). Given the high 
costs to society of managing the ongoing effects on mobility, 
function and independence, strategies are needed to promote 
maximum possible recovery of health, function and independ-
ence. 
Given the impact of fragility fractures on the health system 
and society, there has been a focus on developing programmes 
to promote maximum recovery following hip and other frac-
tures. One approach is to use multidisciplinary rehabilitation 
strategies, which typically involve increased coordination and 
cooperation between a wider variety of healthcare workers than 
in usual care, development of shared goals between the therapy 
team and the patient, and increasing the intensity or duration 
of therapy provided. Previous reviews of multidisciplinary 
rehabilitation strategies have highlighted benefits of such 
programmes through increased return of patients to the com-
munity, less decline in function, reduced length of hospital stay, 
rate of complications, and “poor outcome” (a pooled outcome 
of mortality or admission to a nursing home) (2, 3). Although 
implementing multidisciplinary rehabilitation strategies could 
result in increased expenditure through greater staff input into 
these programmes, in practice previous studies have identified 
cost savings through providing multidisciplinary rehabilita-
tion strategies (4, 5) or only small increases in care costs (6). 
Exercise or physical therapy to prevent and treat functional 
decline and frailty experienced by this group has formed a key 
part of treatment in most multidisciplinary strategies previ-
ously implemented. Extended physical therapy provided in the 
community following discharge has been shown to improve 
mobility, function, strength, balance, and quality of life (QoL) 
compared with standard in-patient provided rehabilitation (7). 
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Malnutrition is common among hip fracture patients and 
has been shown to increase hospitalization costs and length 
of stay, as well as function, strength and mobility outcomes 
(8–14). Nutritional therapy is a key component in the treat-
ment of malnutrition, and a recent meta-analysis of nutritional 
therapy identified improvements in weight status, reduced risk 
of complications and reduced risk of mortality in malnourished 
older adults following treatment with nutrition therapy (15). 
Currently there are no cost-effectiveness studies published 
evaluating the use of combined nutrition and exercise therapy 
for rehabilitation following a hip fracture (16). While physical 
therapy has become a standard aspect of rehabilitation treat-
ment, explicit inclusion of nutrition therapy in the multidisci-
plinary rehabilitation strategies described in the Cochrane Re-
view of multidisciplinary rehabilitation following hip fracture 
is rare (2). Therefore, the aim of this study was to conduct an 
economic evaluation of individualized nutrition and exercise 
therapy programmes for rehabilitation following hip fracture. 
METHODS
Study design
A protocol for the design of the study has been published previously 
(17). Briefly, a randomized controlled trial with blinded outcome 
assessment was undertaken in patients following a fall-related hip 
fracture. Participants were randomly allocated to either: (i) an individu-
alized nutrition and exercise programme; or (ii) attention control for 6 
months. The primary results for the study have not yet been published. 
Recruitment
Participants with a fall-related hip fracture were recruited from 3 
acute care settings in South Australia and New South Wales and 1 
rehabilitation setting in South Australia. Eligibility criteria included 
age 70 years or above, absence of severe cognitive impairment (Mini-
Mental State Examination (MMSE) score of 18 or above out of 30), 
and a body mass index (BMI) of between 18.5 and 35 kg/m2. Exclusion 
criteria included presence of a pathological fracture, admitted from 
a residential aged care facility, unable to communicate with staff in 
English, non-ambulatory pre-fracture or limited to stand transfers only 
post-surgery, or not deemed to be medically stable within 14 days post-
surgery. All participants gave informed consent to participate in the 
trial with additional third party consent gained for those participants 
with an impaired cognitive state (MMSE between 18 and 23) (18).
Intervention
The intervention (commenced within 14 days following survey and 
lasting 6 months) involved a coordinated and individualized care plan 
for each participant, focusing on strength and balance exercises and 
nutritional therapy. The exercises were based on the Otago exercise pro-
gramme, combining strength, balance, and walking training undertaken 
3 times per week (19). Participants were visited by the trial physical 
therapist every 14 days to progress exercises. The nutrition therapy 
aimed at improving dietary intake to meet estimated requirements 
(especially for energy and protein). Dietary strategies included dietary 
counselling focusing on timing, size, and frequency of meals, recom-
mendations of nutrient-rich foods and recipes, referral to community 
meal programmes, and provision of commercial oral nutritional sup-
plements or commercial protein powders as deemed appropriate. Par-
ticipants were visited by the trial dietitian every 14 days (alternately to 
physical therapist visits) to review dietary intake and modify strategies. 
The control group received access to usual rehabilitation programmes 
recommended during hospitalization, social visits weekly from trial 
staff and generic nutrition, exercise and falls prevention information. 
Healthcare costs
A cost-utility analysis was performed combining a measurement of 
the healthcare-related costs associated with the intervention with a 
measure of benefits over the 6 months’ study time-period. Methods 
recommended by the Pharmaceutical Benefits Advisory Committee on 
preparing economic evaluations were utilized (20). The perspective of 
the analysis was of the costs to the healthcare sector, including use of 
community services, such as residential care. Healthcare costs were 
determined by applying accepted unit costs to utilizations of health 
services recorded at the individual level. An overview of the unit 
costs for the healthcare resources included in the analysis is shown 
in Table I. Healthcare utilization was collected from questionnaires 
provided to the patient at weekly visits by trial staff for the duration 
of the 6-month intervention. Utilization of medical and pharmaceutical 
benefits items were requested from the Medical Benefits Scheme and 
the Pharmaceutical Benefits Scheme, which included claims for eligi-
ble pharmaceuticals, medical and other health worker consultations, 
laboratory and radiological procedures, and other medical procedures. 
Unit costs for hospital admission and ambulatory and day reha-
bilitation services were based on Australian data from the National 
Hospital Cost Data Collection (NHCDC) (21–23). A “cost per day” 
was calculated, which included hotel, supply, pharmacy, allied health, 
imaging, pathology, ward nursing, medical, and non-clinical salaries 
and a “once off cost”, which included emergency department, operating 
room, critical care, specialist procedure suites, and prostheses. Unit 
costs per day were then multiplied by the actual length of stay recorded 
for each individual admission. Unit costs for visits from allied health 
practitioners in the community were taken from rebates specified by 
Department of Veterans Affairs (24). Costs were adjusted to 2010 
prices using the relevant consumer price index, as this was the final 
year of recruitment to the study. 
Quality of life
Health-related quality of life (HRQoL) of the study participants was 
measured using the Assessment of Quality of Life (AQoL) instrument, 
now known as the AQoL-4D (25). The AQoL is a generic preference-
based measurement of HRQoL across 5 domains. Participants com-
pleted the 15-item questionnaire at baseline to give a retrospective 
analysis of HRQoL in the 6 months prior to fracture, and in the past 
week at 6-month follow-up. This was to determine the rate of return 
to pre-fracture HRQoL. 
Cost-utility analysis
Effectiveness was measured in terms of quality adjusted life years 
(QALY) gained. The preference-based scoring algorithm developed 
by Hawthorne et al. (25) was used to calculate individual utility scores 
for participants at baseline and at 6 months. The algorithm creates a 
utility value based on the responses to 12 of the 15 items of the AQoL. 
The utility value is created on a scale where zero represents a health 
state equivalent to death and 1 represents perfect or full health. Nega-
tive values are possible, indicating a very poor health state considered 
worse than death. The valuations for the preference based scoring 
algorithm were based on the preference weights of 350 members of 
the Australian general population. 
The economic evaluation was undertaken on an intention to treat 
basis. Discounting of costs was not undertaken, as the time horizon 
of the study was less than 1 year. A utility value of zero was imputed 
for those participants who were deceased at the 6-month follow-up 
point. For the healthcare costs of those who died, a single mean impu-
tation method was utilized, which has been identified as an appropri-
ate method to utilize in cases where the overall rate of missingness 
is small, i.e. less than 5% (26). The QALY gain over the 6-month 
period was calculated using the area under the curve method (27). 
The difference in healthcare costs between the intervention and the 
control group was divided by the difference in QALY gain to give an 
incremental cost-effectiveness ratio (ICER) of cost per QALY gained 
(i.e. ICER=Ca–Cb/Ea–Eb, where Ca is the cost of the intervention, Cb 
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is the cost of the control, Ea is the effectiveness of the intervention, 
Eb is the effectiveness of the control). For calculation of QALY gain, 
baseline AQOL utility scores were imputed based on the scores derived 
in a similar population of older people immediately post hip fracture 
participating in an intervention study (see (28) for the study protocol).
Statistical analysis
Statistical analysis was undertaken using IBM SPSS Statistics Ver-
sion 19.0. Although the likely skewed nature of cost data collected 
for economic evaluations is well described, the standard arithmetic 
mean and t-test were used to compare differences in the costs between 
the groups, as recommended previously (29). Findings are presented 
as mean values with standard deviations, and differences between 
groups as mean difference with 95% confidence intervals. Probabil-
istic sensitivity analysis (PSA) was undertaken using bootstrapping 
to provide an estimate of the uncertainty surrounding the ICER (30). 
This was achieved through re-sampling the original data to replicate 
the results of the ICER 1000 times, giving an empirical estimate of 
the sampling distribution. 
RESULTS
All patients admitted with a hip fracture were screened at the 
4 eligible hospitals over the recruitment period from June 
2007 to April 2010. A total of 1,514 patients were admitted 
across the 4 sites during this period and, of these, 319 were 
eligible. A total of 175 patients (55%) were recruited to the 
trial. Eighty-six participants were randomly allocated to re-
ceive the intervention, while 89 were allocated to the attention 
control. Demographic characteristics were very similar across 
both groups (Table II).
Ten participants out of the 175 (5.7%) refused to complete 
an AQoL assessment or had withdrawn from the study at the 
6-month time-point, and were therefore excluded from the 
cost-utility calculations. Those participants (n = 8, intervention 
n = 4 and control n = 4) who died during the 6-month follow-up 
were allocated a utility score of 0 for the 6-month time-point. 
Costs
Utilization of healthcare resources for the intervention and 
control group over 6 months are shown in Table III. The results 
of the independent samples t-test for comparisons between the 
groups are also shown. An overview of the mean costs for the 
control and intervention groups across the 6-month time-period 
is shown in Table IV. There was little difference in the overall 
healthcare costs between the 2 groups, with a mean difference 
of $AUD 575 (95% CI –5,876 to 7,025, p = 0.861). It can be 
seen that by far the greatest proportion of total costs for both 
intervention and control groups is attributable to hospitaliza-
tions, accounting for a mean of over $AUD 30,000. Overall, the 
additional cost of providing the intervention to the participants 
was approximately $AUD 1,000. The intervention group used 
less resources in post-hospital rehabilitation (ambulatory and 
day rehabilitation) services, other allied health providers, and 
residential and transitional care services than the control group, 
although this did not reach statistical significance. 
Outcomes
The utility of the participant’s self-reported QoL, as measured 
using the AQoL tool, is shown in Table V. There is a small 
difference between the groups at 6 months in favour of the 
Table I. Unit costs for health resources utilized
Healthcare resource Unit Cost per unit updated to 2010 ($AUD) Source
Community allied health visits 1 visit Range between 26.25 up to 122.50 DVA
Trial dietetic or physical therapy visit Per min 2.00 DVA
Trial travel time Per min 2.00 DVA
Car maintenance Per km 0.63 Flinders University 
Oral nutritional supplements 1 tetra pack 2.60 Retail price
Protein powder supplement 1 week supply 7.10 Retail price
Ankle/wrist weights 1 weight 22.00 up to 57.40 size dependant Retail price
Hospitalizations 1 day Based on DRG codes ranging from 642 +  
212/day up to 23,353 + 733/day
NHCDC
Drugs, laboratory tests, doctors and other health worker 
consultations, procedures claimed on Medicare
1 item Based on item numbers ranging from 0.07 to 
3,7291
Medicare
Residential transitional care programme 1 day 262.88 Literature
Ambulatory and day rehabilitation programme 1 day 3,700 + 283.13 NHCDC
High-level care residential care facility 1 day 193.81 DOHA Report
Low-level care residential care facility 1 day 107.85 DOHA Report
Respite at a residential care facility 1 day 72.52 Literature
DRG: diagnostic-related group; DVA: Department of Veterans’ Affairs; NHCDC: National Hospital Cost Data Collection; DOHA: Department of 
Health and Aging.
Table II. Baseline characteristics of participants
Characteristic
Intervention 
(n = 86)
Control 
(n = 89) p-value
Age, years, mean (SD) 82.4 (5.7) 83.0 (6.2) 0.506
Female, n (%) 58 (67.4) 77 (86.5) 0.002
MMSE score, mean (SD) 26 (4) 26 (4) 1
Surgical procedure n (%)
Internal fixation 
Replacement 
53 (61.6)
33 (38.4)
44 (49.4)
45 (50.6)
0.105
0.143
SD: standard deviation; MMSE: Mini-Mental State Examination.
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Table IV. Mean costs for control and intervention groups over 6 months ($AUD)
Resource
Across 6 months
Cost for the intervention 
(n = 86)
Mean (SD)
Cost for the control 
(n = 89)
Mean (SD)
Difference in cost 
Mean (95% CI) 
Total healthcare plus residential care costs 44,840 (22,757) 44,265 (20,448) 575 (–5,876 to 7,025) p = 0.861
Total healthcare only excluding residential care costs 42,626 (19,341) 41,906 (18,364) 719 (–4,906 to 6,346) p = 0.801
Hospitalizations 34,037 (18,114) 33,942 (16,566) 95 (–5,081 to 5,271) p = 0.971
Community, allied health and rehabilitation services 1,747 (4,575) 2,175 (4,874) –427 (–1,839 to 984) p = 0.551
Residential and transition care services 2,242 (6,675) 2,435 (7,042) –193 (–2,242 to 1,856) p = 0.853
Drugs 993 (1,505) 691 (930) 302 (–76 to 681) p = 0.116
Tests 583 (810) 681 (960) –98 (–366 to 169) p = 0.470
Consultations 1,179 (1,435) 1,405 (1,737) –226 (–706 to 254) p = 0.354
Procedures 1,097 (2,058) 1,128 (2,013) –32 (–644 to 581) p = 0.919
Other 54 (176) 69 (234) –16 (–78 to 47) p = 0.621
Intervention 1,125 (1,222) – 1,125 (760 to 1,490) p = 0.000
AUD: Australian dollar; CI: confidence interval; SD: standard deviations.
Table V. Utility score for the intervention and control groups across 6 months
Time-point
Intervention 
Mean (SD)
Control (n = 88)
Mean (SD) Difference (95% CI) in mean 
6 months prior to baseline (n = 174) 0.595 (0.245) 0.592 (0.244) 0.003 (–0.070 to 0.076) p = 0 .93
Imputed baseline1 0.188 (0.192) 0.188 (0.192) –
6 months (n = 165)2 0.498 (0.264) 0.466 (0.297) 0.032 (–0.055 to 0.118) p = 0.47
Regain in utility from baseline to 6 months (n = 164)2 0.157 (0.376) 0.084 (0.379) 0.073 (–0.435 to 0.190) p = 0.218
1Imputed based upon baseline AQoL scores within 7 days following hip fracture from a similar population (n = 99).
2Including imputed value of 0 for participants who were deceased at the time-point.
AQoL: Assessment of Quality of Life; CI: confidence interval; SD: standard deviation.
Table III. Mean utilizations of healthcare resources over 6 months for the intervention and control groups
Resource
Utilizations for the 
intervention
Mean (SD)
Utilizations for the 
control
Mean (SD)
Difference in utilizations 
Mean (95% CI) 
Community dietetics visit 0.0 (0.1) 0.0 (0.3) 0.0 (–0.1 to 0.0) p = 0.263
Community physical therapist visit 1.1 (2.2) 1.2 (2.1) –0.1 (–0.8 to 0.5) p = 0.657
Other allied health visit 0.3 (0.9) 0.5 (1.3) –0.2 (–0.6 to 0.1) p = 0.205
Trial dietetics visit (min) 420.9 (126.0) 273.4 (101.0) 147.5 (113.5 to 181.5) p = 0.000
Trial physio visit (min) 371.0 (98.0) 221.5 (96.8) 149.4 (120.4 to 178.5) p = 0.000
Trial staff travel time (min) 396.4 (417.2) 318.4 (318.4) 77.9 (–39.1 to 195.0) p = 0.191
Oral nutritional supplements 108.9 (91.4) 0.0 (0.0) 108.9 (89.3 to 128.5) p = 0.000
Protein powder supplement 0.4 (1.1) 0.0 (0.0) 0.4 (0.1 to 0.6) p = 0.004
Ankle and wrist weights recommended 1.3 (1.2) 0.0 (0.0) 1.3 (1.1 to 1.6) p = 0.000
Number of days in hospital 32.7 (19.9) 32.5 (20.3) 0.3 (–5.7 to 6.3) p = 0.932
Drugs claimed on Medicare 27.6 (23.9) 22.6 (17.7) 5.0 (–1.4 to 11.3) p = 0.124
Medical tests claimed on Medicare 21.4 (34.1) 22.6 (29.8) –1.1 (–10.7 to 8.5) p = 0.817
Doctor consultations at home or hospital claimed on Medicare 2.5 (4.5) 3.6 (6.5) –1.1 (–2.8 to 0.6) p = 0.198
Doctor consultations in consulting rooms claimed on Medicare 13.8 (14.2) 15.6 (17.7) –1.8 (–6.7 to 3.0) p = 0.456
Residential care facilities consults claimed on Medicare 0.7 (2.9) 0.6 (2.7) 0.1 (–0.7 to 1.0) p = 0.780
Procedures claimed on Medicare 4.2 (6.9) 4.4 (6.9) –0.2 (–2.3 to 1.8) p = 0.821
Other claims on Medicare 0.8 (2.1) 1.0 (3.0) –0.2 (–1.0 to 0.6) p = 0.577
Number of days in residential transitional care programme 4.2 (15.7) 4.2 (17.2) –0.1 (–5.0 to 4.9) p = 0.984
Number of days in the day rehabilitation programme 2.6 (10.2) 2.9 (12.9) –0.3 (–3.8 to 3.2) p = 0.863
Number of days in the ambulatory rehabilitation programme 2.6 (7.8) 3.7 (9.0) –1.1 (–3.6 to 1.4) p = 0.379
Number of days in HLC residential care 4.0 (23.3) 3.7 (20.5) 0.2 (–6.3 to 6.8) p = 0.944
Number of days in LLC residential care 3.3 (21.5) 4.9 (27.1) –1.6 (–9.0 to 5.7) p = 0.659
Number of days in respite in residential aged care facility 0.4 (2.6) 1.1 (5.8) –0.7 (–2.0 to 0.7) p = 0.334
CI: confidence interval; LLC: low-level care; HLC: high-level care; SD: standard deviation.
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intervention indicating the intervention group reported a higher 
mean QoL than the control group, although this did not reach 
statistical significance. 
Overall both groups saw a decrease in utility score for 
HRQoL at 6 months compared with recollections of QoL prior 
to fracture. The mean difference in utility score recollected 
prior to surgery between the groups was extremely small 
(0.003), indicating that both groups recollect their health states 
prior to the fracture as similar. 
Cost-utility analysis
The incremental cost effectiveness ratio (ICER) for the in-
tervention is presented in Table VI, using QALY gain based 
on the utility scores derived from the AQoL. Calculation of 
utilities excluded the small number of participants (n = 10) 
who refused assessment or withdrew from the study at the 
6-month time-point. For those participants who died during the 
follow-up period, given that this was a relatively small number 
of participants (8/165 or 4.9% of total participant group), the 
single mean imputation method was used to impute costs for 
this group (26). 
At 6 months the programme was associated with a small 
additional cost and a gain in QALY relative to usual care with 
social visits. The incremental cost-effectiveness ratio (ICER) 
for the intervention is positive, with a mean of $AUD 28,350 
at 6 months. This ICER is well below the threshold of $AUD 
50,000 estimated as likely to be considered cost-effective by 
the Pharmaceutical Benefits Advisory Committee (PBAC) (31). 
The validity of the base case results at the 6-month time-point 
was confirmed by a PSA using bootstrapping where the original 
data were used to provide an empirical estimate of the sampling 
distribution through repeated re-sampling from the observed 
data (30). The results of the probabilistic sensitivity analysis are 
represented graphically through a cost-effectiveness plane (Fig. 
1) and cost-effectiveness acceptability curve (Fig. 2). 
In interpreting the results of the cost-effectiveness plane, 
observations falling in the north-west quadrant indicate that 
the existing treatment is less costly and more effective than the 
new treatment, and in the south-east quadrant indicate that the 
new treatment is less costly and more effective than the exist-
ing treatment. Observations falling in the north-east quadrant 
indicate that the new intervention is more effective, but also 
more costly than the existing treatment, and in the south-west 
quadrant that the new treatment is considered less effective 
but also less costly than the existing treatment. Decision of 
cost-effectiveness for the north-east and south-west quadrants 
is dependent on whether society considers the change in health 
outcomes or costs acceptable for the change in the alternative. 
For the current study, the cost-effectiveness acceptability 
plane indicates the majority of the observations are in the north-
Table VI. Differences in quality adjusted life years (QALY) gain and cost effects and incremental cost-effectiveness ratio between the intervention 
and control groups over 6 months
Variable
Intervention
Mean (SD)
Control
Mean (SD) Difference in means
Health resource cost ($AUD) (n = 165)a 45,331 (23,012) 44,764 (20,712) 567 (–6,166 to 7,300) p = 0.868
QALY-gain (AQoL) (n = 165)b 0.155 (0.132) 0.139 (0.149) 0.02 (–0.027 to 0.059) p = 0.470
ICER ($AUD) imputation – – 28,350 (intervention dominates to 51,768) 
aIncluding n = 165 participants with complete AQOL data at 6 months.
bIncluding imputed value of 0 for participants who were deceased at the time-point.
AUD: Australian Dollars; AQoL: Assessment of Quality of Life; CI: confidence interval; ICER: incremental cost-effectiveness ratio; SD: standard 
deviation.
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east (38.02% of observations) and south-east quadrants (38.38% 
of observations) of the plane. Therefore, the majority of the 
observations generated through the sensitivity analysis indicate 
either that the intervention provides more health outcomes at a 
lower cost than the existing treatment or provides more health 
outcomes, but at a higher cost than the existing treatment. The 
remainder of the observations are spread in the north-west 
(17.66%) and south-west (5.94%) quadrants of the plane. 
However, the large spread of the data-point cloud in Fig. 1 
indicates the uncertainty in this data. Fig. 2 shows the cost-
effectiveness acceptability curve. Assuming a willingness to 
pay threshold for a QALY of $AUD 50,000, the curve indicates 
a probability that the ICER would fall under this threshold 
of approximately 50%. The relatively flat cost-effectiveness 
acceptability curve (Fig. 2) also indicates a high level of un-
certainty in the cost-effectiveness result based on this data. 
This is partly reflective of the relatively small sample size for 
the randomized control trial coupled with the frail population 
under consideration. In this study, the mean estimates mask a 
wide variation mainly in relation to the frequency of hospital 
admissions and associated lengths of stay. The results range 
from a lower limit whereby the intervention dominates (i.e. it 
is associated simultaneously with a lower costs and a higher 
health gain) relative to a higher limit of $AUD 51,768, which 
is just above the implied Australian societal willingness to pay 
threshold value for a QALY of $AUD 50,000 (31). 
DISCUSSION
While previous studies have evaluated the costs and benefits 
of providing multidisciplinary geriatrician-led care for hip 
fracture patients (4–6, 32), our study is the first to evaluate the 
specific combination of nutrition and exercise therapy over a 
6-month follow-up period. 
A cost-benefit analysis of high-intensity strength training in 
114 patients following a hip fracture found cost savings of $US 
150,974 in the intervention group compared with the control 
through reduced health and social care costs (33), although in 
the current study no significant difference in healthcare costs 
was found (33, 34).
One cost-utility study of nutrition therapy post hip fracture 
has been published, and this identified an ICER Cost/QALY 
of approximately $AUD 54,000 (35). Little change in the 
QALY gain was found between the 2 groups, with a difference 
in means of –0.02 (95% CI –0.12 to 0.08, p > 0.05), which 
accounts for the larger ICER in comparison with the current 
study despite their smaller intervention costs (€613). The study 
used the EQ-5D as their measurement of QoL in the population, 
which the authors hypothesized may not be sensitive enough 
to identify changes in elderly patients. For our study we have 
utilized the AQOL tool, which has the most comprehensive 
descriptive system of any current existing generic preference-
based instrument for the calculation of QALYs and, as such, 
this may have resulted in a more sensitive measurement of QoL. 
The majority of previously identified economic evaluations 
of nutrition or exercise therapy utilize a cost-effectiveness 
or cost-benefit methodology for their analysis (33, 34, 36) 
comparing cost data with a wide variety of monetary or clini-
cal outcomes, such as changes to body composition, length 
of stay, falls and medical complications. These all form im-
portant outcomes in a rehabilitation or nutritional sense, but 
reported individually show only a portion of the benefits to be 
gained in improving the health and wellbeing of patients. On 
the other hand, the benefit of conducting a cost-utility study 
is that it provides a standardized measure of benefits in the 
QALY, which measures the benefits of the intervention broadly, 
and allows comparisons in a unit that maintains its meaning 
across different populations and health sectors, making it the 
preferred method of economic evaluation of regulatory bod-
ies in Australia and around the world (20, 27, 37). It has been 
estimated that in Australian Pharmaceutical Benefits Advisory 
Committee (PBAC) considers interventions evaluated to give 
a cost per QALY of under $AUD 50,000 as highly likely to be 
cost-effective and more likely to be recommended for funding 
(31). Therefore, the individualized nutrition therapy and resist-
ance exercise intervention, by providing improved utility for 
the intervention group compared with the control group across 
6 months at a ICER of $AUD 28,000, is likely to be considered 
cost-effective. However, this result should be interpreted with 
caution, as the results of the cost-effectiveness acceptability 
curve indicate just over 50% certainty that the ICER would fall 
under the accepted $AUD 50,000/QALY range. Another factor 
to be considered in interpreting the results is that the control 
group included social visits that impacted on the costs and 
QoL for this group, and therefore the ICER in an intervention 
with these social visits may or may not also indicate likely 
cost-effectiveness. 
Our study has some limitations. It is evident that there is wide 
variability in the cost data in our sample, with the probabilistic 
sensitivity analysis indicating that the true value for the ICER 
for QALY probably lies somewhere between the intervention 
dominating (i.e. provides both an improvement in QoL and 
reduction in costs) ranging up to a cost of $AUD 51,000 per 
QALY gained, which is just above the accepted upper threshold 
of cost-effectiveness in Australia. This probably eventuates 
from the wide range in the total costs for the participants, linked 
to the wide variation in number of hospital admissions, length 
of stay, and complications experienced. However, this situation 
is not unusual in economic analysis of treatment studies where 
the majority of participants will produce a moderate cost, but 
a few participants may experience more severe and rare health 
problems, which can have an exponential effect on costs (27) 
and is especially known to occur in populations of frail older 
adults, such as in this study (38, 39). Whilst the variability in 
the cost outcomes for the sample is reflected in the confidence 
intervals for the base case ICER, it is also important to note 
that the majority of the data-points estimated through the PSA 
remain under the upper implied threshold limit for the cost-
effectiveness ratio in Australia (31). 
A second limitation is the use of an imputed value for QoL at 
baseline. The QoL of the participants at baseline was measured 
as the QoL in the 6 months prior to the intervention. However, 
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for calculating QALY gain between the 2 groups, an assess-
ment of utility at the commencement of the intervention was 
required (27). Therefore, the mean utility score taken from a 
similar population of patients in the first 2 weeks following 
surgery for hip fracture was imputed for all participants in the 
QALY calculation (28). While this allows us to calculate the 
QALY gain for each group, it does not allow us to account for 
any differences in utility at baseline that may have been present 
in the 2 groups. Therefore, it is important to acknowledge that 
a difference in utility between the groups at baseline many 
have existed, which could influence differences in utility at 
the 6-month time-point. When asked about their utility in the 
6 months prior to fracture, there was virtually no difference 
between the 2 groups. In addition, socio-demographic factors 
shown to influence QoL, such as age and cognitive status (40, 
41), were similar between the 2 groups. Hence it may be rea-
sonable to conclude that utility in the groups at the baseline 
time-point was also similar. 
In summary, the aim of this study was to conduct a cost-
utility study of a multidisciplinary nutrition and exercise 
therapy rehabilitation programme in patients following surgery 
for hip fractures. The results indicate that the intervention 
delivered an incremental QALY gain relative to usual care 
with attention control at a small additional cost, and hence 
demonstrates likely cost-effectiveness. However, future re-
search should focus on larger samples of participants to provide 
more precision to the economic estimates and to provide more 
definitive evidence on the effectiveness of combined nutrition 
and exercise therapy. Longer time-frames of follow-up are also 
important to economic trials in this area, as the benefits of 
providing this therapy may lie not only with the effects on the 
current admission to healthcare services, but also in preventing 
subsequent admissions, or in reducing complicated care needs 
during those admissions. The potential effect of nutrition and 
exercise therapy in this age group as a moderator of hospital 
length of stay and complications experienced also provides a 
strong basis to measure resource use in micro-level approaches 
such as using diagnostic-related group-based costing in future 
studies. In addition, given the large impact that residential care 
admission made to total costs despite the relatively few patients 
who were admitted to care, resource use in this sector should 
be included in future economic evaluations in this population. 
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